Humanin gene expression in subjects with Parkinson's disease.
Expression
Humanin gene
Parkinson’s disease
qRT-PCR
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
19
08
2022
accepted:
16
11
2022
pubmed:
11
1
2023
medline:
16
3
2023
entrez:
10
1
2023
Statut:
ppublish
Résumé
Bradykinesia, tremor, rigidity and postural instability are the hallmark of Parkinson's disease (PD). Non-motor symptoms including cognitive, behavioral, and neuropsychiatric changes, sensory and sleep disturbances that may precede the motor symptoms by years. The peculiar pathological features of PD are decreased dopaminergic neurons and dopamine levels in the substantia nigra pars compacta and pontine locus coeruleus. Humanin is produced by a small gene peptide, which is located in the mitochondria genome. Inflammation, oxidative stress, mitochondrial dysfunction and altered transcription have been recognized as causative factors of PD. This evidence has prompted many researchers to focus on studying the functions of DNA and mitochondria. The purpose of the present study was to evaluate Humanin mRNA levels in peripheral blood mononuclear cells (PBMCs) of PD subjects, compared with those in PBMCs of normal control (NC) subjects. A total of 220 participants, including 154 PD patients (57 females and 97 males; mean age 71.54 years, SD 7.8) and 66 CN (28 females and 38 males; mean age 70.54 years, SD 9.45) were enrolled for the qRT-PCR analysis. Increased Humanin mRNA levels were found in PD samples, compared to controls. In conclusion, the present data confirm the tendency of mitochondria to overexpress mRNA in PD, which could be a cellular attempt to reduce apoptotic damage in PD subjects. Humanin might be useful as a marker for a better diagnosis of PD, and we cannot exclude that in the future it might also play a role on prognosis and in the possible therapies for PD.
Sections du résumé
BACKGROUND
BACKGROUND
Bradykinesia, tremor, rigidity and postural instability are the hallmark of Parkinson's disease (PD). Non-motor symptoms including cognitive, behavioral, and neuropsychiatric changes, sensory and sleep disturbances that may precede the motor symptoms by years. The peculiar pathological features of PD are decreased dopaminergic neurons and dopamine levels in the substantia nigra pars compacta and pontine locus coeruleus. Humanin is produced by a small gene peptide, which is located in the mitochondria genome. Inflammation, oxidative stress, mitochondrial dysfunction and altered transcription have been recognized as causative factors of PD. This evidence has prompted many researchers to focus on studying the functions of DNA and mitochondria. The purpose of the present study was to evaluate Humanin mRNA levels in peripheral blood mononuclear cells (PBMCs) of PD subjects, compared with those in PBMCs of normal control (NC) subjects.
METHODS AND RESULTS
RESULTS
A total of 220 participants, including 154 PD patients (57 females and 97 males; mean age 71.54 years, SD 7.8) and 66 CN (28 females and 38 males; mean age 70.54 years, SD 9.45) were enrolled for the qRT-PCR analysis. Increased Humanin mRNA levels were found in PD samples, compared to controls.
CONCLUSION
CONCLUSIONS
In conclusion, the present data confirm the tendency of mitochondria to overexpress mRNA in PD, which could be a cellular attempt to reduce apoptotic damage in PD subjects. Humanin might be useful as a marker for a better diagnosis of PD, and we cannot exclude that in the future it might also play a role on prognosis and in the possible therapies for PD.
Identifiants
pubmed: 36626066
doi: 10.1007/s11033-022-08132-3
pii: 10.1007/s11033-022-08132-3
doi:
Substances chimiques
humanin
0
Intracellular Signaling Peptides and Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2943-2949Subventions
Organisme : The Italian "5 x 1000" funding
ID : The Italian "5 x 1000" funding
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1–29. doi: https://doi.org/10.1016/j.freeradbiomed.2013.03.018
doi: 10.1016/j.freeradbiomed.2013.03.018
pubmed: 23567191
Guadagnolo D, Piane M, Torrisi MR, Pizzuti A, Petrucci S (2021) Genotype-phenotype correlations in monogenic Parkinson Disease: a review on clinical and molecular findings. Front Neurol 12:648588. doi: https://doi.org/10.3389/fneur.2021.648588
doi: 10.3389/fneur.2021.648588
pubmed: 34630269
pmcid: 8494251
Xu S, Zhang X, Liu C, Liu Q, Chai H, Luo Y et al (2021) Role of Mitochondria in neurodegenerative Diseases: from an epigenetic perspective. Front Cell Dev Biol 9:688789. doi: https://doi.org/10.3389/fcell.2021.688789
doi: 10.3389/fcell.2021.688789
pubmed: 34513831
pmcid: 8429841
Sharma N, Pasala MS, Prakash A (2019) Mitochondrial DNA: epigenetics and environment. Environ Mol Mutagen 60(8):668–682. doi: https://doi.org/10.1002/em.22319
doi: 10.1002/em.22319
pubmed: 31335990
pmcid: 6941438
Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y et al (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Abeta. Proc Natl Acad Sci USA 98(11):6336–6341. doi: https://doi.org/10.1073/pnas.101133498
doi: 10.1073/pnas.101133498
pubmed: 11371646
pmcid: 33469
Yen K, Mehta HH, Kim SJ, Lue Y, Hoang J, Guerrero N et al (2020) The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan. Aging 12(12):11185–11199. doi: https://doi.org/10.18632/aging.103534
doi: 10.18632/aging.103534
pubmed: 32575074
pmcid: 7343442
Hazafa A, Batool A, Ahmad S, Amjad M, Chaudhry SN, Asad J et al (2021) Humanin: a mitochondrial-derived peptide in the treatment of apoptosis-related diseases. Life Sci 264:118679. doi: https://doi.org/10.1016/j.lfs.2020.118679
doi: 10.1016/j.lfs.2020.118679
pubmed: 33130077
Matsuoka M (2009) Humanin; a defender against Alzheimer’s disease? Recent patents on CNS drug discovery 4(1):37–42. doi: https://doi.org/10.2174/157488909787002609
Bachar AR, Scheffer L, Schroeder AS, Nakamura HK, Cobb LJ, Oh YK et al (2010) Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress. Cardiovascular Res 88(2):360–366. doi: https://doi.org/10.1093/cvr/cvq191
doi: 10.1093/cvr/cvq191
Minasyan L, Sreekumar PG, Hinton DR, Kannan R (2017) Protective mechanisms of the mitochondrial-derived peptide humanin in oxidative and endoplasmic reticulum stress in RPE cells. Oxidative medicine and cellular longevity 1675230. https://doi.org/10.1155/2017/1675230
Moretti E, Giannerini V, Rossini L, Matsuoka M, Trabalzini L, Collodel G (2010) Immunolocalization of humanin in human sperm and testis. Fertil Steril 94(7):2888–2890. doi: https://doi.org/10.1016/j.fertnstert.2010.04.075
doi: 10.1016/j.fertnstert.2010.04.075
pubmed: 20542501
Yen K, Wan J, Mehta HH, Miller B, Christensen A, Levine ME et al (2018) Humanin prevents Age-Related Cognitive decline in mice and is Associated with Improved Cognitive Age in humans. Sci Rep 8(1):14212. doi: https://doi.org/10.1038/s41598-018-32616-7
doi: 10.1038/s41598-018-32616-7
pubmed: 30242290
pmcid: 6154958
Wu Y, Sun L, Zhuang Z, Hu X, Dong D (2021) Mitochondrial-derived peptides in diabetes and its complications. Front Endocrinol 12:808120. doi: https://doi.org/10.3389/fendo.2021.808120
doi: 10.3389/fendo.2021.808120
Thiankhaw K, Chattipakorn K, Chattipakorn SC, Chattipakorn N (2022) Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition. Biochimica et biophysica acta. Gen Subj 1866(4):130097. https://doi.org/10.1016/j.bbagen.2022.130097
doi: 10.1016/j.bbagen.2022.130097
Salemi M, Cannarella R, Marchese G, Salluzzo MG, Ravo M, Barone C, Cordella A, Caniglia S, Castiglione R, Ragalmuto A, Calogero AE, Romano C (2021) CCR3 gene overexpression in patients with Down syndrome. Mol Biol Rep 48(6):5335–5338. doi: https://doi.org/10.1007/s11033-021-06503-w . Epub 2021 Jun 28. PMID:34184200
doi: 10.1007/s11033-021-06503-w
pubmed: 34184200
Salemi M, Ridolfo F, Salluzzo MG, Cannarrella R, Giambirtone M, Caniglia S et al (2020) Humanin gene expression in fibroblast of Down syndrome subjects. Int J Med Sci 17(3):320–324. doi: https://doi.org/10.7150/ijms.39145
doi: 10.7150/ijms.39145
pubmed: 32132866
pmcid: 7053358
Salemi M, Cimino L, Marino M, Cannarella R, Condorelli RA, Romano C et al (2018) Next Generation sequencing expression profiling of mitochondrial subunits in men with Klinefelter syndrome. Int J Med Sci 15(1):31–35. doi: https://doi.org/10.7150/ijms.21075
doi: 10.7150/ijms.21075
pubmed: 29333085
pmcid: 5765737
Conte M, Ostan R, Fabbri C, Santoro A, Guidarelli G, Vitale G et al (2019) Human aging and longevity are characterized by high levels of Mitokines. The journals of gerontology Series A, Biological sciences and medical sciences. 74:600–607. https://doi.org/10.1093/gerona/gly153 . 5
Widmer RJ, Flammer AJ, Herrmann J, Rodriguez-Porcel M, Wan J, Cohen P et al (2013) Circulating humanin levels are associated with preserved coronary endothelial function. Am J Physiol Heart Circ Physiol 304(3):H393–H397. doi: https://doi.org/10.1152/ajpheart.00765.2012
doi: 10.1152/ajpheart.00765.2012
pubmed: 23220334
Xu Y, Wang Q, Qu Z, Yang J, Zhang X, Zhao Y (2019) Protective effect of hyperbaric oxygen therapy on cognitive function in patients with vascular dementia. Cell Transplant 28(8):1071–1075. doi: https://doi.org/10.1177/0963689719853540
doi: 10.1177/0963689719853540
pubmed: 31134827
pmcid: 6728711
Zhang W, Miao J, Hao J, Li Z, Xu J, Liu R et al (2009) Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices. Peptides 30(6):1197–1202. doi: https://doi.org/10.1016/j.peptides.2009.02.017
doi: 10.1016/j.peptides.2009.02.017
pubmed: 19463756
Zhang W, Du Y, Bai M, Xi Y, Li Z, Miao J (2013) S14G-humanin inhibits Abeta1-42 fibril formation, disaggregates preformed fibrils, and protects against Abeta-induced cytotoxicity in vitro. J Pept science: official publication Eur Pept Soc 19(3):159–165. doi: https://doi.org/10.1002/psc.2484
doi: 10.1002/psc.2484
Niikura T, Sidahmed E, Hirata-Fukae C, Aisen PS, Matsuoka Y (2011) A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. PLoS ONE 6(1):e16259. doi: https://doi.org/10.1371/journal.pone.0016259
doi: 10.1371/journal.pone.0016259
pubmed: 21264226
pmcid: 3022031
Qin Q, Mehta H, Yen K, Navarrete G, Brandhorst S, Wan J et al (2018) Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice. Am J Physiol Heart Circ Physiol 315(5):H1127–H36. doi: https://doi.org/10.1152/ajpheart.00685.2017
doi: 10.1152/ajpheart.00685.2017
pubmed: 30004252
pmcid: 6415743
Solanki A, Smalling R, Parola AH, Nathan I, Kasher R, Pathak Y et al (2019) Humanin nanoparticles for reducing pathological factors characteristic of age-related Macular Degeneration. Curr Drug Deliv 16(3):226–232. doi: https://doi.org/10.2174/1567201815666181031163111
doi: 10.2174/1567201815666181031163111
pubmed: 30381074
Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T (2004) Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol Cell Neurosci 25(1):95–102. doi: https://doi.org/10.1016/j.mcn.2003.09.017
doi: 10.1016/j.mcn.2003.09.017
pubmed: 14962743
Kunesova G, Hlavacek J, Patocka J, Evangelou A, Zikos C, Benaki D et al (2008) The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues. Peptides 29(11):1982–1987. doi: https://doi.org/10.1016/j.peptides.2008.06.019
doi: 10.1016/j.peptides.2008.06.019
pubmed: 18647630
Murakami M, Nagahama M, Abe Y, Niikura T (2017) Humanin affects object recognition and gliosis in short-term cuprizone-treated mice. Neuropeptides 66:90–96. doi: https://doi.org/10.1016/j.npep.2017.10.002
doi: 10.1016/j.npep.2017.10.002
pubmed: 29070438
Murakami M, Nagahama M, Maruyama T, Niikura T (2017) Humanin ameliorates diazepam-induced memory deficit in mice. Neuropeptides 62:65–70. doi: https://doi.org/10.1016/j.npep.2016.10.008
doi: 10.1016/j.npep.2016.10.008
pubmed: 27814910
Zarate SC, Traetta ME, Codagnone MG, Seilicovich A, Reines AG (2019) Humanin, a mitochondrial-derived peptide released by astrocytes, prevents synapse loss in hippocampal neurons. Front Aging Neurosci 11:123. doi: https://doi.org/10.3389/fnagi.2019.00123
doi: 10.3389/fnagi.2019.00123
pubmed: 31214013
pmcid: 6555273
Salemi M, Cosentino F, Lanza G, Cantone M, Salluzzo MG, Giurato G et al (2021) mRNA expression profiling of mitochondrial subunits in subjects with Parkinson’s disease. Archives of Medical Science. doi: https://doi.org/10.5114/aoms/131629
doi: 10.5114/aoms/131629
Salemi M, Cantone M, Salluzzo MG, Giambirtone M, Spada R, Ferri R (2017) Reduced mitochondrial mRNA expression in dementia with Lewy bodies. J Neurol Sci 380:122–123. doi: https://doi.org/10.1016/j.jns.2017.07.020
doi: 10.1016/j.jns.2017.07.020
pubmed: 28870550
Zaccaria A, Antinori P, Licker V, Kövari E, Lobrinus JA, Burkhard PR (2022) Multiomic analyses of dopaminergic neurons isolated from human Substantia Nigra in Parkinson’s Disease: a descriptive and exploratory study. Cell Mol Neurobiol Nov 42(8):2805–2818. doi: https://doi.org/10.1007/s10571-021-01146-8
doi: 10.1007/s10571-021-01146-8
Malczynska-Sims Paulina and Chalimoniuk, Malgorzata and Sulek, Anna, Circulating Cytokine Levels Correlate with the GFAP, S100beta and White Blood Cells in the Early Stage of Parkinson’s Disease. Available at SSRN: https://ssrn.com/abstract=4237725
Bagheri V, Khorramdelazad H, Hassanshahi G, Moghadam-Ahmadi A, Vakilian A (2018) CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson’s Disease. Neuroimmunomodulation. 2018;25(4):201–205